JPWO2020071551A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020071551A5 JPWO2020071551A5 JP2020551127A JP2020551127A JPWO2020071551A5 JP WO2020071551 A5 JPWO2020071551 A5 JP WO2020071551A5 JP 2020551127 A JP2020551127 A JP 2020551127A JP 2020551127 A JP2020551127 A JP 2020551127A JP WO2020071551 A5 JPWO2020071551 A5 JP WO2020071551A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- seq
- analogue
- epithelial
- therapeutic agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018190461 | 2018-10-05 | ||
| JP2018190461 | 2018-10-05 | ||
| PCT/JP2019/039383 WO2020071551A1 (ja) | 2018-10-05 | 2019-10-04 | 良性腫瘍の予防または治療薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2020071551A1 JPWO2020071551A1 (ja) | 2021-09-24 |
| JPWO2020071551A5 true JPWO2020071551A5 (https=) | 2023-02-15 |
| JP7393752B2 JP7393752B2 (ja) | 2023-12-07 |
Family
ID=70054693
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020551127A Active JP7393752B2 (ja) | 2018-10-05 | 2019-10-04 | 良性腫瘍の予防または治療薬 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12440546B2 (https=) |
| EP (1) | EP3865146A4 (https=) |
| JP (1) | JP7393752B2 (https=) |
| KR (1) | KR102901715B1 (https=) |
| CN (1) | CN113395976B (https=) |
| AU (1) | AU2019352354B2 (https=) |
| CA (1) | CA3115240A1 (https=) |
| MX (1) | MX2021003938A (https=) |
| TW (1) | TWI851607B (https=) |
| WO (1) | WO2020071551A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2973548T3 (es) | 2016-12-22 | 2024-06-20 | Cue Biopharma Inc | Polipéptidos multiméricos moduladores de linfocitos T y métodos para su uso |
| WO2021230638A1 (en) * | 2020-05-12 | 2021-11-18 | Lg Chem, Ltd. | Multimeric t-cell modulatory polypeptides and methods of use thereof |
| WO2021231376A2 (en) | 2020-05-12 | 2021-11-18 | Cue Biopharma, Inc. | Multimeric t-cell modulatory polypeptides and methods of use thereof |
| CN120484057A (zh) * | 2025-05-07 | 2025-08-15 | 宁夏医科大学总医院 | 一种治疗结直肠息肉的短肽及其制备方法 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP940432B1 (en) | 1994-08-05 | 2003-10-31 | Pliva Pharm & Chem Works | Dna sequences encoding biosynthetic insulin precursors and process for preparation of insulin |
| AU4932199A (en) * | 1998-07-31 | 2000-02-21 | Haruo Sugiyama | Cancer antigens based on tumor suppressor gene wt1 product |
| AU5161800A (en) * | 1999-05-24 | 2000-12-12 | Board Of Regents, The University Of Texas System | Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases |
| EP1371664B1 (en) | 2001-03-22 | 2008-01-09 | International Institute of Cancer Immunology, Inc. | Wti modified peptide |
| WO2003106682A1 (ja) | 2002-06-12 | 2003-12-24 | 中外製薬株式会社 | Ｈｌａ−ａ２４拘束性癌抗原ペプチド |
| WO2004024175A1 (ja) * | 2002-09-12 | 2004-03-25 | Haruo Sugiyama | 癌抗原ペプチド製剤 |
| ES2331305T3 (es) | 2002-09-20 | 2009-12-29 | International Institute Of Cancer Immunology, Inc. | Peptidos de wt1 de tipo sustituido. |
| CN101098708A (zh) * | 2004-11-10 | 2008-01-02 | 胡布雷希特实验室 | 通过抑制Notch途径激活治疗肠腺瘤和/或腺癌 |
| CA2631292C (en) | 2005-11-30 | 2014-05-06 | International Institute Of Cancer Immunology, Inc. | Derivatised wt1 cancer antigen peptides and their use |
| CA2940962C (en) * | 2007-12-05 | 2018-07-24 | International Institute Of Cancer Immunology, Inc. | Cancer vaccine composition |
| WO2012037551A2 (en) * | 2010-09-17 | 2012-03-22 | Irx Therapeutics, Inc. | Primary cell-derived biologic and wt1 synthetic long peptide vaccine |
| JP6117515B2 (ja) * | 2011-11-01 | 2017-04-19 | 国立大学法人名古屋大学 | 髄膜腫治療用医薬組成物 |
| EP2793916A1 (en) * | 2011-12-20 | 2014-10-29 | North Carolina State University | Methods to reduce polyposis and colorectal cancer |
| SG11201507883SA (en) * | 2013-03-29 | 2015-10-29 | Sumitomo Dainippon Pharma Co Ltd | Wt1-antigen peptide conjugate vaccine |
| ES2841274T3 (es) | 2014-08-04 | 2021-07-07 | Hutchinson Fred Cancer Res | Inmunoterapia con células T específica para WT-1 |
| ES2805094T3 (es) | 2014-12-11 | 2021-02-10 | Int Inst Cancer Immunology Inc | Inmunoterapia WT1 para enfermedad angiogénica intraocular |
| CN107921106B (zh) * | 2015-05-20 | 2023-09-08 | 住友制药株式会社 | Wt1抗原肽和免疫调节剂的组合用途 |
| SMT202200370T1 (it) * | 2015-11-20 | 2022-11-18 | Memorial Sloan Kettering Cancer Center | Composizione per il trattamento del cancro |
| JPWO2018181648A1 (ja) | 2017-03-30 | 2020-02-13 | 大日本住友製薬株式会社 | Ｗｔ１癌抗原ペプチドおよびこれを含むペプチドコンジュゲート体 |
| JP6741049B2 (ja) | 2018-08-07 | 2020-08-19 | カシオ計算機株式会社 | 注文処理装置及びプログラム |
-
2019
- 2019-10-04 CA CA3115240A patent/CA3115240A1/en active Pending
- 2019-10-04 US US17/282,172 patent/US12440546B2/en active Active
- 2019-10-04 MX MX2021003938A patent/MX2021003938A/es unknown
- 2019-10-04 AU AU2019352354A patent/AU2019352354B2/en active Active
- 2019-10-04 WO PCT/JP2019/039383 patent/WO2020071551A1/ja not_active Ceased
- 2019-10-04 KR KR1020217012141A patent/KR102901715B1/ko active Active
- 2019-10-04 TW TW108136125A patent/TWI851607B/zh active
- 2019-10-04 CN CN201980080769.XA patent/CN113395976B/zh active Active
- 2019-10-04 EP EP19868580.2A patent/EP3865146A4/en active Pending
- 2019-10-04 JP JP2020551127A patent/JP7393752B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7404306B2 (ja) | 卵巣がんおよびその他のがんに対する免疫療法において使用するための新規ペプチドおよびペプチドの組み合わせ | |
| ES2849187T3 (es) | Método para activar células T auxiliares | |
| JP2024037858A (ja) | 卵巣がんおよびその他のがんに対する免疫療法において使用するための新規ペプチドおよびペプチドの組み合わせ | |
| JP6901065B2 (ja) | Ｎｓｃｌｃをはじめとする肺がんおよびその他のがんに対する免疫療法において使用するための新規ペプチドおよびペプチド組み合わせ | |
| ES2387685T3 (es) | Péptido WT1 restringido por HLA-A*3303 y composición farmacéutica que comprende el mismo | |
| JP6970974B2 (ja) | 様々ながんの免疫治療で使用するための新規ペプチド、ペプチドおよびスキャフォールド組み合わせ | |
| JP5230579B2 (ja) | 癌抑制遺伝子ｗｔ１の産物に基づく癌抗原 | |
| JPWO2020071551A5 (https=) | ||
| ES2805337T3 (es) | Método para activar células T auxiliares | |
| JP2022033740A (ja) | 頭頸部扁上皮がんおよびその他のがんに対する免疫療法で使用するための新規ペプチドおよびスキャフォールド | |
| JP2017525336A5 (https=) | ||
| KR20180055826A (ko) | 소세포 폐암 및 기타 암에 대한 면역요법에서의 사용을 위한 펩티드 및 펩티드의 조합 | |
| IL309003A (en) | Novel peptides, combination of peptides and scaffolds for use in immunothera-peutic treatment of various cancers | |
| JP6990935B2 (ja) | 膵臓がんおよびその他のがんに対する免疫療法において使用するための新規ペプチドおよびペプチドの組み合わせ | |
| CN106243213B (zh) | 一种肿瘤相关抗原XAGE-1b短肽及应用 | |
| KR102901715B1 (ko) | 양성 종양의 예방 또는 치료약 | |
| JP7266834B2 (ja) | 腫瘍抗原ペプチド | |
| CN107261111A (zh) | 免疫诱导剂 | |
| JP6959597B2 (ja) | 腫瘍抗原ペプチド | |
| CN105531368A (zh) | 肿瘤抗原肽 | |
| CN106279391B (zh) | 肿瘤相关抗原XAGE-1b短肽及应用 | |
| WO2007058235A1 (ja) | 融合蛋白質およびその薬学的用途 | |
| CN110016073A (zh) | 一种XAGE-1b九肽及其应用 | |
| WO2011112599A2 (en) | Immunogenic pote peptides and methods of use |